Digital Biomarker Market Segmentation by System Component (Data Collection Tools, and Data Integration Systems); by Therapeutic Area (Cardiovascular Diseases, Neurodegenerative Disorders, Sleep and Movement Diseases, Psychiatric Disorders, Chronic Pain, Gastrointestinal Diseases, Diabetes, Other Diseases); by Application (Wellness, Disease Diagnosis and Development); by Development Status; and by End Users – Global Demand Analysis & Opportunity Outlook 2030

Global Digital Biomarker Market Highlights 2019-2030

The global digital biomarker market attained revenue of USD 1,043.3 Million in 2019 and is estimated to garner USD 46,131.4 Million in 2030 by growing at a CAGR of 41.22% over the forecast period i.e., 2020-2030. One of the major factors that can be attributed to the growth of the market can be the growing usage of healthcare-based mobile apps and the emerging mHealth or mobile health industry. Moreover, increasing smartphone penetration worldwide, along with the increasing internet use, are also expected to create numerous opportunities for market growth. According to the statistics by Pew Research Center, smartphone ownership in the United States grew from 35% in the year 2011 to 85% in the year 2021. Additionally, smartphone ownership amongst the U.S. citizens aged 65+ grew from 3% in 2013 to 12% in 2021. The market is also thriving on account of the rising incidences of chronic diseases worldwide, and the growing burden of chronic diseases amongst the nations. According to the statistics by the United States Centers for Disease Control and Prevention (CDC), the leading causes of death and disability in the U.S. costs the country USD 3.8 Trillion in annual healthcare costs. Additionally, growing adoption of smart wearables is also expected to provide numerous opportunities for market growth during the forecast period. The market is also expected to grow on account of the increasing application of digital biomarkers to diagnose various neurological disorders, such as Alzheimer’s disease.

Get more information on this report: Download Sample PDF

Global Digital Biomarker Market Segmentation Regional Synopsis

Regionally, the global digital biomarker market is segmented into five major regions comprising North America, Asia Pacific, Europe, South America, and Middle East & Africa. Among the markets in these regions, the North America digital biomarker market is estimated to hold leading market share throughout the forecast period. The market in the region registered a market value of USD 512.3 Million in the year 2019 and is further expected to reach USD 20796 Million by the end of 2030. The market in the region is also expected to grow with a CAGR of 40.13% during the forecast period. The market is further segmented by country into the U.S., Canada, and Mexico, out of which, the market in the U.S. is anticipated to garner the largest revenue of USD 778.2 Million by the end of 2021. The growth of the market in the country can be attributed to the growing adoption of telehealth services, followed by the availability of a strong healthcare infrastructure, and increase in spending by the government of the country for advancements in medical research. The U.S. digital biomarker market is segmented by therapeutic area into cardiovascular diseases, neurodegenerative disorders, sleep & movement diseases, psychiatric disorders, chronic pain, gastrointestinal diseases, diabetes, respiratory conditions, and others, out of which, the neurodegenerative disorders segment is expected to hold the largest revenue of USD 4250.80 Million by the end of 2030. On the other hand, the market in the Asia Pacific is expected to grow with the highest CAGR of 44.09% during the forecast period.

Growth Drivers and Challenges Impacting the Growth of the Global Digital Biomarker Market

Growth Drivers

• Rising Demand for Mobile Health Apps
• Rising Penetration of Smartphones & Wearables
• Increasing Concern for Chronic Diseases Worldwide

Challenges

• Rising Security Concerns

Global Digital Biomarker Market Segmentation Synopsis

The global digital biomarker market is segmented by system component into data collection tools and data integration systems. Out of these, the data integration systems segment is expected to hold the highest CAGR of 41.50% during the forecast period. Based on therapeutic area, the market is segmented into cardiovascular diseases, neurodegenerative disorders, sleep & movement diseases, psychiatric disorders, chronic pain, gastrointestinal diseases, diabetes, respiratory conditions, and others. Amongst these segments, the neurodegenerative disorders segment is expected to grab the largest market revenue of USD 11836.7 Million by the end of 2030. The market is further segmented by application into wellness, disease diagnosis, personalized medication, and drug discovery & development. Out of these, the drug discovery & development segment is expected to hold the largest market share throughout the forecast period and register a revenue of USD 16732.40 Million by the end of 2030. Further, based on development status, the market is segmented into novel digital biomarkers, original digital biomarkers, and approved digital biomarkers. Out of these, the approved digital biomarkers segment is expected to hold the largest market revenue of USD 21105 Million by the end of 2030. The market is also segmented based on end user into biopharmaceutical companies & labs, healthcare providers, and insurance payers, out of which, the biopharmaceutical companies & labs segment is expected to hold the largest revenue of USD 29089.10 Million by the end of 2030.

Key Players Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global digital biomarker market that are included in our report are ActiGraph LLC, Akili Interactive Labs, Inc., AliveCor, Inc., Altoida, Inc., Biogen Inc., ConnectedLife Health Pte Ltd, Cambridge Cognition Ltd, Evidation Health, Inc., Fitbit, Inc., Happify, Inc., Human API, GlaxoSmithKline plc, Huma, IXICO plc, Kinsa Inc., Koneksa, Medical Care Corporation, Mindstrong Health, Koninklijke Philips N.V., Neurotrack Technologies, Inc., Novartis AG, ResMed, F. Hoffmann-La Roche Ltd, Winterlight Labs, Verily Life Sciences LLC, and others.

Key Reasons to Buy Our Report

• The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
• It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
• The report includes detailed company profiles of the major players dominating the market.
• We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
• We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.